US Dollar Index remains fragile around 98.40 amid anticipation of a second round of US-Iran negotiations
US Dollar Remains Weak Amid Ceasefire Hopes
The US Dollar continues to struggle, holding onto losses from Monday as optimism grows regarding ongoing efforts between the United States and Iran to secure a lasting ceasefire. Although the initial round of discussions in Pakistan over the weekend did not yield significant progress, both sides remain committed to further negotiations.
Currently, the US Dollar Index (DXY)—which measures the currency against six major counterparts—is trading steadily around 99.37, marking its lowest point in more than six weeks.
Earlier today, US Vice President JD Vance spoke with Fox News, describing the talks with Iranian representatives as “productive.” He noted that his team gained important insights into Iran’s negotiation tactics and expressed optimism about a second round of discussions, stating, “We’ve built momentum, and now it’s up to Iran to move the process forward.”
Additionally, CNN reported that US officials are internally planning for a possible follow-up meeting with Iranian delegates before the current ceasefire deadline on April 21.
Domestically, traders have ruled out the likelihood of the Federal Reserve raising interest rates, especially as falling oil prices and positive US-Iran developments continue to put pressure on the US Dollar.
Looking ahead, investors are set to pay close attention to the US Producer Price Index (PPI) for March, scheduled for release at 12:30 GMT on Tuesday.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs Upgrades CoreWeave to "Buy": Market Overestimates Financing Costs and Underestimates Computing Fee Capabilities
Goldman Sachs has upgraded CoreWeave’s rating from “Neutral” to “Buy,” with a target price of $106, offering approximately 73% upside from the latest closing price of $61.39. Goldman Sachs believes the market is overly concerned about CoreWeave’s financing costs but underestimates its charging potential for computing power: asset-backed financing supported by GPU and customer contracts is not entirely tied to corporate bond yields. Additionally, annual revenue per megawatt is expected to rise from the current $10 million to $13 million, improving investment returns.
AI Credit Pressure Surfaces: CoreWeave Bonds Become the New Barometer for the US Stock Market
CoreWeave's unsecured bonds have replaced Nvidia as the market's "beta barometer" for measuring AI trades. The bonds’ yields have surged past 16% and CDS spreads have soared, highlighting the high dependence of emerging cloud computing companies on debt financing and their funding gap risks. Credit pressures are spreading from infrastructure to equity markets, and the main focus of AI trading has shifted from computing power demand to financing costs and sustainability.
GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window
The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.
After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"
Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.
Crypto prices
More
